The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.

Improvements in diagnostic methods for the diagnosis of genetic and chronic diseases are highly prioritized all across the globe. There are lots of advancements pertaining to the effective diagnosis of genetic diseases; however, there remains a lack of adoption of technologically advanced equipment in emerging economies. Most of the developing economies in the world still opt for manual instruments in the field of research and diagnostics on account of financial feasibility.

Market Segmentation

Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)

Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)

Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)

Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)

End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)

Regional Segmentation

North America: U.S., Canada

Europe: Germany, France, U.K., Italy, Spain, Netherlands, Denmark, Belgium, Switzerland, and Rest-of-Europe

Asia-Pacific: China, Japan, India, South Korea, Australia, Singapore, and Rest-of-Asia-Pacific

Latin America: Brazil, Mexico, and Rest-of-Latin America

Rest-of-the-World

Market Growth Drivers

Increasing Use of NGS for Genetic Disorders

Technological Advancements in NGS Sample Preparation Methods

Rising Research Funding in the Field of Genomics

Market Challenges

High Cost of Automated NGS Sample Preparation Instruments

Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Countries

Stringent Regulatory Standards

Market Opportunities

Adoption of Automated NGS Sample Preparation in the Emerging Markets

Rising Direct-to-Consumer Testing

Key Companies Profiled

Agilent Technologies, Inc., Aurora Biomed Inc., Danaher, Bio-Rad Laboratories, Inc., Eppendorf SE, Opentrons, BGI Group, Promega Corporation, Oxford Nanopore Technologies plc., F. Hoffmann-La Roche Ltd, Tecan Trading AG, Hamilton Company, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., New England Biolabs, QIAGEN, Pacific Biosciences of California, Inc

Request a Sample - https://bisresearch.com/requestsample?id=1249type=download